Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013594-25-000742
Filing Date
2025-06-12
Accepted
2025-06-12 20:17:31
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6974
  Complete submission text file 0001013594-25-000742.txt   8693
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 180 LAKEVIEW AVENUE WEST PALM BEACH FL 33401
Business Address
Paulson John (Reporting) CIK: 0001394923 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 251044490